Viveve Medical (VIVE) Stock Price, News & Analysis

Company Overview

Viveve Medical, Inc. is a medical technology company focused on the development and commercialization of non-invasive solutions for women’s intimate health. The company’s flagship offering, the Viveve System, employs proprietary cryogen-cooled monopolar radiofrequency energy to gently heat and remodel vaginal tissue. This technology is designed to address conditions such as vaginal laxity and associated symptoms, offering a single-treatment protocol that can be performed in a clinical setting without the need for anesthesia.

Regulatory clearances, including U.S. Food and Drug Administration (FDA) 510(k) authorization, underpin the safety profile of the Viveve System. The company’s research and development efforts have centered on optimizing treatment parameters and expanding the application of its proprietary energy-delivery platform. Viveve Medical also provides training and support to healthcare professionals in aesthetic, urogynecology and gynecology practices to ensure consistent clinical outcomes and patient satisfaction.

Since its founding in 2009 and subsequent initial public offering on the NASDAQ in 2015 under the ticker VIVE, Viveve Medical has pursued a global commercialization strategy. The company’s products are available in key markets across North America, Latin America, Europe and Asia through a combination of direct sales and distribution partnerships. By focusing exclusively on women’s intimate wellness, Viveve Medical aims to establish a differentiated position within the broader medical aesthetics and women’s health markets.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 4,549 shs
• Market Capitalization: $1 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VIVE Stock Analysis - Frequently Asked Questions

How were Viveve Medical's earnings last quarter?

Viveve Medical, Inc. (NASDAQ:VIVE) announced its quarterly earnings data on Thursday, November, 11th. The company reported ($0.67) EPS for the quarter, missing analysts' consensus estimates of ($0.58) by $0.09. The company earned $1.62 million during the quarter.

When did Viveve Medical IPO?

Viveve Medical (VIVE) raised $13 million in an initial public offering (IPO) on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group acted as the underwriters for the IPO and Maxim Group was co-manager.

How do I buy shares of Viveve Medical?

Shares of VIVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Viveve Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), NIO (NIO) and Western Digital (WDC).

Company Calendar

• Last Earnings: 11/11/2021
• Today: 9/10/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:VIVE
• Previous Symbol: OTCMKTS:PLCSD
• CIK: 879682
• Web: www.viveve.com
• Phone: (720) 696-8100
• Fax: 720-696-8199
• Employees: 70
• Year Founded: 2005

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $6.83 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 10,670,000
• Free Float: N/A
• Market Cap: $1 thousand
• Optionable: Not Optionable
• Beta: 0.03